Heart and Lung Outcomes Post-TB (HALO Post-TB) NIH R01HL176528Sep 25, 2024 - Jun 30, 2029 Role: Principal Investigator |
REVERSE-Long COVID: A Multicenter Randomized, Placebo-Controlled Clinical Trial of Immunomodulation (with Baricitinib) for Long COVID Related ADRD NIH R01AG085873Jan 1, 2024 - Dec 31, 2028 Role: Co-Principal Investigator |
Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV) NIH R01HL170600Jul 5, 2023 - Jun 30, 2027 Role: Principal Investigator |
Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) NIH R01HL164337Aug 5, 2022 - Jul 31, 2027 Role: Principal Investigator |
Cell-Type Specific Mechanisms of HIV Cardiomyopathy NIH R01HL158315Dec 6, 2021 - Nov 30, 2025 Role: Co-Principal Investigator |
Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection NIH R01HL152957Aug 20, 2020 - Jul 31, 2024 Role: Co-Principal Investigator |
In Vivo PET Imaging of HIV Infection NIH R01AI152932Aug 12, 2020 - Jul 31, 2026 Role: Co-Principal Investigator |
UCSF Career Development Program in Cardiopulmonary, Hematologic, and Immunologic Comorbidities of HIV (CHIC) NIH K12HL143961Aug 1, 2018 - Jun 30, 2024 Role: Principal Investigator |
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) NIH R33HL141047Feb 1, 2018 - Jan 31, 2024 Role: Principal Investigator |
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) NIH R61HL141047Feb 1, 2018 - Jan 31, 2019 Role: Principal Investigator |
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans NIH R01HL129856Sep 1, 2016 - Jun 30, 2021 Role: Principal Investigator |
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV NIH R01HL125034Apr 1, 2015 - Aug 31, 2021 Role: Principal Investigator |
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV NIH R56HL125034Sep 11, 2014 - Mar 31, 2015 Role: Principal Investigator |
Role of Hematopoietic System and Proteomics in HIV-Associated Cardiovascular Disease NIH K24AI112393Mar 1, 2014 - Feb 28, 2025 Role: Principal Investigator |
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV NIH U01HL121819Sep 26, 2013 - Jul 31, 2019 Role: Co-Principal Investigator |
Effect of low dose methotrexate on endothelial function and inflammation in HIV NIH R01HL117713Sep 26, 2012 - Apr 30, 2019 Role: Principal Investigator |
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection NIH R01HL095130Sep 25, 2008 - Jun 30, 2015 Role: Principal Investigator |
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients NIH R01HL091526Sep 16, 2007 - Jul 31, 2013 Role: Principal Investigator |
Pathogenesis of Atherosclerosis in HIV Patients on HAART NIH K23AI066885Jul 15, 2005 - May 31, 2010 Role: Principal Investigator |